Latest Expert Opinions

Signal
Opinion
Expert
WEAK BUY
WEAK BUY
May 9, 2018

He likes medical device manufacturers. It seems they are taking market share in a booming market. They are well diversified. The company continues to put up great numbers.

Show full opinionHide full opinion

He likes medical device manufacturers. It seems they are taking market share in a booming market. They are well diversified. The company continues to put up great numbers.

COMMENT
COMMENT
May 9, 2018

They are well diversified. Rising interest rates will be good for them. He would lean into the U.S. insurance space as he prefers a little more laser focus. Overall, he would favour investing in US financials, such as Schwab or E-Trade instead of insurance.

Show full opinionHide full opinion

They are well diversified. Rising interest rates will be good for them. He would lean into the U.S. insurance space as he prefers a little more laser focus. Overall, he would favour investing in US financials, such as Schwab or E-Trade instead of insurance.

SPECULATIVE BUY
SPECULATIVE BUY
May 9, 2018

He has not done a lot of work on this company, but is aware they have been putting up monster earnings results. They are consistent earnings beaters, but when there are not on guidance, it is usually earnings lower than target. This makes the stock too risky for his conservative investments, but would consider it a speculative buy.

Show full opinionHide full opinion

He has not done a lot of work on this company, but is aware they have been putting up monster earnings results. They are consistent earnings beaters, but when there are not on guidance, it is usually earnings lower than target. This makes the stock too risky for his conservative investments, but would consider it a speculative buy.

BUY
BUY
May 9, 2018

He thinks they are ideally positioned for the movement to cloud based storage. Estimates are that global cloud storage has increased by 90% over the past 18 months. They put up a good earnings surprise and are doing well.

Show full opinionHide full opinion

He thinks they are ideally positioned for the movement to cloud based storage. Estimates are that global cloud storage has increased by 90% over the past 18 months. They put up a good earnings surprise and are doing well.

COMMENT
COMMENT
May 9, 2018

He does not like the materials space right now as there is no upward momentum in this sector presently. Given recent inflation trends, it is not being confirmed with upward price movements. He would not go here.

Show full opinionHide full opinion

He does not like the materials space right now as there is no upward momentum in this sector presently. Given recent inflation trends, it is not being confirmed with upward price movements. He would not go here.

DON'T BUY
DON'T BUY
May 9, 2018

The technical chart is not showing any upward momentum. Policy factors and other issues are not fundamentally supportive. The sector is a bond proxy and this is not the time to be investing in this space as interest rates are moving up. He questions if the dividend is safe. This is not a defensive stock with rising interest rates, which he expects will rise to 4%. Yield 6%.

Show full opinionHide full opinion
A T & T US (T-N)
May 9, 2018

The technical chart is not showing any upward momentum. Policy factors and other issues are not fundamentally supportive. The sector is a bond proxy and this is not the time to be investing in this space as interest rates are moving up. He questions if the dividend is safe. This is not a defensive stock with rising interest rates, which he expects will rise to 4%. Yield 6%.

DON'T BUY
DON'T BUY
May 9, 2018

They completed a $5 billion buyback recently. They put up a beat on recent earnings, but there were concerns about future earnings. He does not like the space as there is a wall of sellers to overcome and bio-tech is running out of technical momentum. They have great forecasted cash flow, but watch out if they miss their guidance.

Show full opinionHide full opinion

They completed a $5 billion buyback recently. They put up a beat on recent earnings, but there were concerns about future earnings. He does not like the space as there is a wall of sellers to overcome and bio-tech is running out of technical momentum. They have great forecasted cash flow, but watch out if they miss their guidance.